REG - CT UK High Inc Tst CT UK High Inc-CHIB - Result of AGM

CT UK High Income TrustAnnouncement

28/07/2025 17:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250728:nRSb8676Sa&default-theme=true

RNS Number : 8676S  CT UK High Income Trust PLC  28 July 2025

To:                   RNS

From:              CT UK High Income Trust PLC

Date:               28 July 2025

LEI:                  213800B7D5D7RVZZPV45

 

Information disclosed in accordance with UKLR 6.4.13

 

Subject: Result of Annual General Meeting

 

CT UK High Income Trust PLC (the 'Company') announces that, at the Annual
General Meeting held on 28 July 2025, a poll was held on each of the 14
resolutions proposed and all were duly passed, including those detailed below:

 

·    An ordinary resolution renewing the Directors' authority to allot new
Ordinary shares of 0.1 pence each up to an aggregate nominal amount of £8,547
(which equates to 8,547,000 Ordinary shares) and allot new B shares of 0.1
pence each up to an aggregate nominal amount of £1,522 (which equates to
1,522,000 B shares), being approximately 10.0% of the Company's total issued
Ordinary shares (excluding shares held in treasury) and approximately 5.0% of
the Company's total issued B shares respectively (excluding shares held in
treasury) as at 29 May 2025. This authority will expire at the conclusion of
the Company's next Annual General Meeting to be held after the passing of this
resolution or on 30 September 2026, whichever is earlier, unless previously
revoked, varied or extended by the Company in general meeting.

 

·    A special resolution renewing the Directors' authority to allot new
Ordinary shares of 0.1 pence each up to an aggregate nominal amount of £8,547
(which equates to 8,547,000 Ordinary shares) and allot new B shares of 0.1
pence each up to an aggregate nominal amount of £1,522 (which equates to
1,522,000 B shares) being approximately 8.4% of the Company's total issued
Ordinary shares (including shares held in treasury) and approximately 4.7% of
the Company's total issued B shares respectively (including shares held in
treasury) as at 29 May 2025, for cash without first offering such shares to
existing shareholders pro rata to their existing holdings. This authority will
expire at the conclusion of the Company's next Annual General Meeting to be
held after the passing of this resolution or on 30 September 2026, whichever
is earlier unless previously varied, revoked or renewed by the Company in
general meeting.

 

·    A special resolution renewing the Directors' authority to make market
purchases of up to 12,812,300 Ordinary shares and 4,565,700 B shares being
approximately 14.99% of the issued Ordinary shares and 14.99% of the issued B
shares (excluding Ordinary shares and B shares held in treasury). This
authority will expire at the conclusion of the Company's next Annual General
Meeting held after the passing of this resolution or on 30 September 2026,
whichever is the earlier, unless previously varied, revoked or renewed by the
Company in general meeting.

 

·    A special resolution renewing the Directors' authority to sell shares
from treasury without having first to make a pro rata offer to existing
shareholders limited up to an aggregate nominal amount of £8,547 in respect
of Ordinary shares and £3,045 in respect of B shares, representing
approximately 8.4% of the Company's Ordinary share capital in issue (including
treasury shares) and approximately 9.5% of the Company's B share capital in
issue (including treasury shares) as at 29 May 2025. This authority shall
expire at the conclusion of the next Annual General Meeting of the Company
held after the passing of this resolution or on 30 September 2026, whichever
is the earlier, unless previously varied, revoked or renewed by the Company in
general meeting.

 

·    An ordinary resolution that the aggregate limit, contained within the
Company's articles of association for directors' fees, that the directors may
be paid be increased from £175,000 per annum to £200,000 per annum.

 

The results of the poll were as follows:

                                                                                  For and Discretionary         Against                       Withheld             Total Votes (excluding Votes Withheld)
     Resolution                                                                   No of Votes  % of Votes Cast  No of Votes  % of Votes Cast     No of

                                                                                                                                                 Votes
 1   Receive and adopt the Annual Report & Financial Statements for the year      71,068,327   99.99            6,253        0.01             605,278              71,074,580
     ended 31 March 2025
 2   Approve Directors' Remuneration Report for the year ended 31 March 2025      64,719,973   95.84            2,808,950    4.16             4,150,935            67,528,923
 3   To re-elect H M Galbraith as a Director                                      66,663,267   96.48            2,430,063    3.52             2,586,528            69,093,330
 4   To re-elect S J Mitchell as a Director                                       66,051,373   95.60            3,041,957    4.40             2,586,528            69,093,330
 5   To re-elect A W Pottinger as a Director                                      66,973,377   96.93            2,122,167    3.07             2,584,314            69,095,544
 6   To re-elect A K Watkins as a Director                                        66,316,241   95.95            2,796,018    4.05             2,567,599            69,112,259
 7   To re-appoint Deloitte LLP as Auditor                                        66,165,851   94.56            3,803,148    5.44             1,710,859            69,968,999
 8   To authorise the Directors to determine the remuneration of the Auditor      69,229,251   99.25            525,650      0.75             1,924,957            69,754,901
 9   Approval of the Company's dividend/capital repayment policy                  69,032,057   99.61            273,043      0.39             2,374,758            69,305,100
 10  Authorise the Directors to allot shares                                      68,235,248   98.87            776,585      1.13             2,668,025            69,011,833
 11  Authority to allot shares without pre-emption rights                         66,265,320   95.99            2,770,795    4.01             2,643,743            69,036,115
 12  Authority to purchase own shares                                             66,922,332   96.64            2,325,549    3.36             2,431,977            69,247,881
 13  Authority to sell treasury shares without pre-emption rights                 65,824,899   96.01            2,737,987    3.99             3,116,972            68,562,886
 14  That the aggregate limit, in the Company's Articles for directors' fees, be  58,175,264   88.93            7,242,415    11.07            6,262,179            65,417,679
     increased to £200,000 p.a.

The full text of all the resolutions can be found in the Notice of Annual
General Meeting set out in the Annual Report and Financial Statements of CT UK
High Income Trust PLC for the year ended 31 March 2025, which was submitted to
the National Storage Mechanism on 5 June 2025 and is available for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) and on the Company's
website www.ctukhighincome.co.uk (http://www.ctukhighincome.co.uk)  A copy of
the poll results will also be available on the Company's website.

At the time of the meeting the Company's issued share capital consisted of
85,472,653 Ordinary shares carrying one vote each and 30,458,750 B shares
carrying one vote each.  The Company holds 16,594,491 Ordinary shares and
1,617,953 B shares in treasury which do not carry voting rights. Therefore,
the total voting rights in the Company were 115,931,403 votes.

For further information please contact:

Columbia Threadneedle Investment Business Limited
            0131 573 8300

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGUWVVRVKUBUAR